Publication | Closed Access
Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis
11
Citations
16
References
2023
Year
NMV-r can reduce all-cause hospitalization and mortality among patients with LC who have COVID-19.
| Year | Citations | |
|---|---|---|
Page 1
Page 1